S23 (Most Potent SARM)
Experimental SARM studied mainly in rats, unproven in humans; it shuts down the body’s own testosterone production and may damage the liver.


The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Related comparisons
LGD-4033 vs S23 vs S4DETAILED OVERVIEW
What is S23 (Most Potent SARM)?
S23 is an experimental compound, one of the non-steroidal substances called SARMs, which trigger male-hormone-like effects in muscle and bone. It was never approved as a medicine and is sold as a research chemical. It was originally studied as a hormonal contraceptive for men: in rats it temporarily stopped sperm production, but no clinical trial in humans was started.
In rat studies it was found to be the most potent of the SARMs, but its effect is not proven in humans. Bodybuilders report fast muscle gain, but these are only personal experiences. It completely shuts down the body’s own testosterone production, and recovery of fertility can take months. It can damage the liver, may lower HDL cholesterol, and irritability and aggression have been reported. In women it can cause rapid, partly irreversible masculinization, and in pregnancy it can harm the baby. It is banned in competitive sport year-round.
Mechanism
Non-steroidal; binds the androgen receptor most strongly in its class
Anabolic activity (Jones 2009)
~95% testosterone-level in vivo (rat bioassay). Higher than RAD-140.
Half-life
~12 h (oral)
Onset
1-2 weeks
Legal status
Never an Rx (Phase I never started in humans). UGL 'research chemical'. WADA-banned S1.2.
No anecdote collected yet.
Data console
Lab data
Chen J, Hwang DJ, Bohl CE, Miller DD, Dalton JT . A selective androgen receptor modulator for hormonal male contraception.. J Pharmacol Exp Ther.
Jones A, Chen J, Hwang DJ, Miller DD, Dalton JT . Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception.. Endocrinology.
Mohamed WT, Jahagirdar V, Fatima I, Ahmed MK, Goyal A, Sodeman T, Anwar N . Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature.. Cureus.
Labban H, Kwait B, Paracha A, Khan A, Singh M, Lopez R . LGD-4033 and a Case of Drug-Induced Liver Injury: Exploring the Clinical Implications of Off-Label Selective Androgen Receptor Modulator Use in Healthy Adults.. Cureus.
Leciejewska N, Jędrejko K, Gómez-Renaud VM, Manríquez-Núñez J, Muszyńska B, Pokrywka A . Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases.. Eur J Clin Pharmacol.
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Complete HPTA suppression and arrest of spermatogenesis: as a strong AR agonist S23 drives LH/FSH suppression via negative feedback; in rats (Jones 2010) 1–3 mg/day caused reversible azoospermia, with fertility recovery taking 3–6 months (no human data).
- Hepatotoxicity (SARM-induced liver injury): hepatocellular / cholestatic DILI cases documented for the SARM class (Cureus, Eur J Clin Pharmacol case reports) apply to S23; ALT/AST/GGT elevation, jaundice and raised bilirubin may occur.
- Severe lipid disturbance: marked HDL cholesterol drop typical of SARMs (up to ~50%), unfavourable LDL/HDL shift, and elevated long-term cardiovascular risk.
- Prostate androgenic effect: S23 is less tissue-selective than other SARMs (Ostarine, S4), with high AR activity in the prostate as well – PSA elevation and prostate stimulation are possible.
- Androgenic skin and hair effects: acne, increased sebum production, and male-pattern hair loss in predisposed individuals.
- Mood and behavioural changes: anecdotal user reports of increased irritability, aggression and sleep disturbance, which may worsen with a psychiatric predisposition.
- Testosterone-suppression symptoms during and after the cycle: reduced libido, fatigue, testicular shrinkage (–40% testis mass in 4 weeks in rats), and low mood with prolonged recovery if no PCT is used.
Contraindications · 7
- Planning fatherhood / conception in the near or mid term: absolutely avoid given S23's strong, documented suppression of spermatogenesis (azoospermia in rats), with fertility recovery taking 3–6 months or longer.
- Pre-existing liver disease or elevated baseline ALT/AST: an absolute contraindication due to SARM-DILI risk.
- Women, especially during or planning pregnancy: the high-potency androgenic AR activity can cause rapid, partly irreversible virilization (voice deepening, hirsutism, clitoral enlargement) and fetal harm.
- Prostate disease, elevated PSA or a history of prostate cancer: contraindicated because of S23's non-selective, high prostate AR activity.
- Cardiovascular disease or dyslipidemia: the marked HDL drop and adverse lipid profile worsen pre-existing risk.
- Psychiatric predisposition (depression, anxiety, aggression/impulse disorders): avoid due to mood side effects and HPTA-suppression-related mood deterioration.
- Concurrent alcohol use, other hepatotoxic agents or stacking with other SARMs/AAS: avoid due to cumulative liver and HPTA burden; also for competitive athletes (WADA-banned year-round, S1.2).
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
A selective androgen receptor modulator for hormonal male contraception.
Chen J, Hwang DJ, Bohl CE, Miller DD, Dalton JT
Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception.
Jones A, Chen J, Hwang DJ, Miller DD, Dalton JT
Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature.
Mohamed WT, Jahagirdar V, Fatima I, Ahmed MK, Goyal A, Sodeman T, Anwar N
LGD-4033 and a Case of Drug-Induced Liver Injury: Exploring the Clinical Implications of Off-Label Selective Androgen Receptor Modulator Use in Healthy Adults.
Labban H, Kwait B, Paracha A, Khan A, Singh M, Lopez R
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases.
Leciejewska N, Jędrejko K, Gómez-Renaud VM, Manríquez-Núñez J, Muszyńska B, Pokrywka A
Telegram
Have a question about S23 (Most Potent SARM)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.